Author's reply  by Golledge, J. & Davies, A.H.
320 Correspondence 
sonography causes damage to bypasses? We think not. 
Another interesting fact which can be extracted from 
the data is the difference of the ratio of amputation/ 
occlusion between the two series of publications. Here 
again we have only taken into account he articles 
which give us complete data. For the non-surveillance 
group this ratio is 355/804 (44%), for the bypasses 
with surveillance 69/103 (67%). The difference be- 
tween these two ratios is 23% (99% confidence interval 
10-36%). 
All this leads to the conclusion that comparing these 
two groups of publications was wrong, because the 
more modern series of publications describing by- 
passes with surveillance which are different from those 
described in the historical series of articles without 
surveillance. 
H. Bruijnen and K.D. W61fle 
Augsburg, Germany 
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Author's Reply 
We thank Drs Bruijnen and WOlfle for their comments. 
We are not aware of any evidence to suggest that using 
the difference of proportions provides superior as- 
sessment ofthe data compared to the Chi-squared test. ~ 
We are also well aware that the control group is his- 
torical and this was pointed out in the second paragraph 
of the discussion. Such disparity is unavoidable, given 
that most vascular units now employ duplex sur- 
veillance. Duplex surveillance has important economic 
and workload implications, and we therefore feel that 
the value of duplex surveillance in improving outcome 
following infrainguinal vein bypass needs to be dem- 
onstrated. Simply to explain any failure to demonstrate 
improvement in outcomes by a more aggressive inter- 
vention policy is unsatisfactory. 
It was suggested that the total occlusion rate was 
higher in the control group as a result of improved 
intraoperative control measures. As discussed in our 
paper this seems unlikely, as there was no difference 
in the perioperative occlusion rates for the two groups 
(Table 4). As stated in our paper "In order to have 
some measure of ischaemia, rest pain and gangrene 
have been grouped together as critical ischaemia nd 
compared to claudication" (p. 391). 
Why does a total occlusion rate of 27% only lead to 
an amputation rate of 13%, i.e. 50% of occluded bypass 
grafts require amputation of the leg despite critical 
ischaemia being present in 70%? Clearly the eventual 
outcome following graft occlusion in the presence of 
critical ischaemia will depend on a large number of 
factors such as the outcome of any secondary pro- 
cedure, the state of run-off vessels following occlusion, 
the medical condition of the patient and therefore their 
suitability for further reconstructive surgery. Let us 
assume that 100 grafts occlude, with 50% eventually 
come to amputation (i.e. 50). Assuming the same rate 
of critical ischaemia in the occluded grafts, then 30 
patients with occluded grafts may not require further 
intervention to avoid amputation. This leaves 20 
patients (20%) in which secondary intervention 
achieves limb salvage. We do not feel such a scenario 
is so unlikely. 
We emphasised in our article that the reporting rates 
of amputation are different in the two groups "Hence 
the importance of comparing the definite end point 
of limb salvage or amputation. However, since this 
outcome measure israrely documented in surveillance 
series, this has been extremely difficult." (p. 391). The 
figures quoted for the publication of Thompson et al. 
have been correctly quoted. The 206 reconstructions 
also include prosthetic grafts which were not included 
in our analysis. Only 110 of the reconstructions were 
vein grafts, the five amputations are stated in their 
related publication. 2 
The subset analysis performed on our data has been 
calculated incorrectly. If we study Tables 2 and 3 
and if we concentrate only on the articles reporting 
amputation rates, the figures should be as follows: 
without surveillance 804 occlusions in 2957 (27%), with 
surveillance 133 occlusions in 664 (20%), while the 
amputation rates are 357/2957 (12%) for non-sur- 
veillance and 85/664 (13%) for the surveillance series. 
The ratio of amputation toocclusion is 357/804 (45%) 
for non-surveillance and 85/133 (64%) for surveillance 
series, i.e. a difference of 19%, not 23%. It is implied 
that the occlusion to amputation rate should be the 
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same for series with similar rates of critical ischaemia. 
Is this necessarily the case? Let us study the few 
surveillance series which quote amputation rates. In 
the publication of Sayer et al.9 in which all patients 
are stated to have critical ischaemia, 25 of the 33 (75%) 
occluded grafts resulted in amputations. Whereas in 
the article of Berkowitz and Greenstein, 4 in which all 
patients are stated to have severely ischaemic legs, 
only 11 of the 25 (44%) occluded grafts resulted in 
amputation. Clearly there appears to be variation in 
the outcome of graft occlusion in the presence of 
critical ischaemia. Thus any analysis based on the 
hypothesis that the ratio of occlusion to amputation 
is equal must be invalid. 
As stated in the discussion of our publication, we 
accept hat the summation analysis has a number of 
difficulties. The results do not demonstrate hat duplex 
surveillance has no role following infrainguinal by- 
pass, but they do indicate that a large randomised trial 
is warranted to establish that the considerable cost 
and workload required for surveillance isworthwhile. 
Surely this is the only scientific way of establishing 
the role of duplex surveillance rather than any hypo- 
thesis that the ratio of amputation to occlusion should 
be equal for disparate groups or the demonstration 
that secondary patency is significantly better than 
primary patency3 
J. Golledge and A.H. Davies 
Charing Cross Hospital, London, U.K. 
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Iloprost 
Sir, 
Having been involved with the early trials of iloprost as 
an adjunct o distal bypass urgery, we were naturally 
disappointed that the multi-centre trial reported in 
this journal failed to show any benefit of the agent in 
this role. 1 We believe, however, that the results of the 
study should be interpreted with great caution for a 
number of reasons. 
Initial experience with iloprost was carried out using 
a single bolus dose of the agent via a vein graft to a single 
calf vessel on completion of the procedure. Addition of 
intravenous iloprost before and after surgery is without 
proven benefit and may, as the authors discuss, even 
be disadvantageous. It is further disappointing that 45 
patients failed to receive iloprost as planned. 
Our major concern relates to the study design. The 
initial power calculations for the study were based on 
the results of patients undergoing arterial bypass to a 
single calf vessel using long saphenous vein. In the re- 
ported study only 73.9% of patients received such a 
procedure, and the inclusion of patients with composite 
and prosthetic grafts invalidates the initial calculations. 
Subsequent subgroup analysis of the different grafts is 
not valid due to the small numbers and is possibly one of 
the factors contributing to the surprising lack of benefit 
found for vein compared to prosthetic grafts. 
Patient selection and surgical technique are of fun- 
damental importance in distal bypass urgery, and the 
variation in number of procedures performed by each 
centre (one unit contributing only one) suggests con- 
siderable differences existed. This point is reinforced by 
the variable use of dextran, antiplatelet agents, heparin 
and anaesthetic technique. All of these factors introduce 
further variables which reduce the power of the study. 
It is likely that publication of this study will kill 
further interest in the role of iloprost as an adjunct o 
distal bypass surgery. We think that this may be a 
pity and suggest hat what the study most strongly 
illustrates is the need for robust study design before 
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Transcranial Doppler 
Sir, 
We read with interest he article of Giannoni et al. 1 
regarding the changes seen on transcranial doppler 
compared with clinical condition when performing a
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